Cannabinoid consumption during pregnancy has been increasing on the wave of the broad-based legalisation of cannabis in Western countries, raising concern about the putative detrimental outcomes on foetal neurodevelopment. Indeed, since the endocannabinoid system regulates synaptic plasticity, emotional and cognitive processes from early stages of life interfering with it and other excitability endogenous modulators, such as neuropeptide Y (NPY), might contribute to the occurrence of a vulnerable phenotype later in life.
|Number of pages||17|
|Journal||Journal of Psychopharmacology|
|Publication status||Published - 2020|
All Science Journal Classification (ASJC) codes
- Psychiatry and Mental health
- Pharmacology (medical)